21502680

Source:http://linkedlifedata.com/resource/pubmed/id/21502680

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001721, umls-concept:C0012854, umls-concept:C0019169, umls-concept:C0023911, umls-concept:C0034897, umls-concept:C0038952, umls-concept:C0243071, umls-concept:C0328104, umls-concept:C0332835, umls-concept:C0376387, umls-concept:C0441889
pubmed:issue	2
pubmed:dateCreated	2011-4-19
pubmed:abstractText	The risk of recurrent hepatitis B virus (HBV) infection and prognosis of liver transplantation in patients with HBV has dramatically changed with the use of prophylaxis including hepatitis B immune globulin (HBIg) and antiviral agents.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101155885
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Nucleosides, http://linkedlifedata.com/resource/pubmed/chemical/Nucleotides, http://linkedlifedata.com/resource/pubmed/chemical/hepatitis B hyperimmune globulin
pubmed:status	MEDLINE
pubmed:issn	1665-2681
pubmed:author	pubmed-author:BilbaoItxaroneI, pubmed-author:ButiMaríaM, pubmed-author:Campos-VarelaIsabelI, pubmed-author:CastellsLluísL, pubmed-author:CharcoRamónR, pubmed-author:EstebanRafaelR, pubmed-author:GuardiaJaimeJ, pubmed-author:JardíRosendoR, pubmed-author:Rodríguez-FríasFranciscoF, pubmed-author:VargasVíctorV
pubmed:issnType	Print
pubmed:volume	10
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	180-7
pubmed:meshHeading	pubmed-meshheading:21502680-Adult, pubmed-meshheading:21502680-DNA, Viral, pubmed-meshheading:21502680-Female, pubmed-meshheading:21502680-Graft Rejection, pubmed-meshheading:21502680-Hepatitis B, Chronic, pubmed-meshheading:21502680-Hepatitis B virus, pubmed-meshheading:21502680-Humans, pubmed-meshheading:21502680-Immunoglobulins, pubmed-meshheading:21502680-Immunosuppressive Agents, pubmed-meshheading:21502680-Liver Failure, pubmed-meshheading:21502680-Liver Transplantation, pubmed-meshheading:21502680-Male, pubmed-meshheading:21502680-Middle Aged, pubmed-meshheading:21502680-Nucleosides, pubmed-meshheading:21502680-Nucleotides, pubmed-meshheading:21502680-Predictive Value of Tests, pubmed-meshheading:21502680-Preoperative Care, pubmed-meshheading:21502680-Proportional Hazards Models, pubmed-meshheading:21502680-Recurrence, pubmed-meshheading:21502680-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:21502680-Risk Factors, pubmed-meshheading:21502680-Survival Analysis, pubmed-meshheading:21502680-Viral Load
pubmed:articleTitle	Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues?
pubmed:affiliation	Liver Unit, Department of Internal Medicine, Hospital Universitario Vall d' Hebron, Barcelona, Spain. icampos@vhebron.net
pubmed:publicationType	Journal Article